BCG Treatment for Bladder Cancer

Links shared publicly online about this topic

The Management Of BCG Failure In Non-muscle-invasive Bladder Cancer: An Update

medicalnewstoday.com — “UroToday.com - A major dilemma among patients with non-muscle-invasive bladder cancer (NMIBC) and their physicians is the choice of an appropriate course of action following failure of intravesicaView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 14, 2010 at 1:05 pm By:

mnt_urology MNT Urology Health News

The Management Of BCG Failure In Non-muscle-invasive Bladder Cancer: An Update http://mnt.to/3DPs #urology

2 years ago...

Gemcitabine May Hold Promise for BCG Failures in Bladder Cancer Patients - Renal and Urology News

renalandurologynews.com — “Gemcitabine might be a second-line treatment option for patients with high-risk non-muscle-invasive bladder cancer (BC) who fail therapy with bacille Calmette-Gurin (BCG), according to Italian researchers.View full resource at renalandurologynews.com

  • View Related
  • Share

Most Recently Shared on February 25, 2010 at 2:32 pm By:

renalandurology Renal Urology News Urology, Medical Publisher, Health News, and Nephrology

Gemcitabine May Hold Promise for BCG Failures in Bladder Cancer Patients: Gemcitabine might be a second-line treat... http://bit.ly/bgwU3B

2 years ago...

Trial Backs Maintenance BCG for Bladder Cancer - QualityPoint Technologies

qualitypointtech.net — “Patients with non-muscle-invasive bladder cancers have a clear recurrence-free survival advantage from long-term therapy with bacillus Calmette-Guerin (BCG) therapy after resection, a new multicenter study confirms. Reuters Health InformationView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on January 6, 2011 at 7:00 pm By:

MedicalFeed MedicalFeed Health News Feed

Trial Backs Maintenance BCG for Bladder Cancer: Patients with non-muscle-invasive bladder cancers have a clear rec... http://bit.ly/h5A84K

1 year ago...

Valstar available again for treatment of bladder cancer - MPR

empr.com — “Endo Pharmaceuticals has launched Valstar (valrubicin), an anthracycline derivative, for the treatment of Bacille Calmette-Guerin (BCG)-refractory carcinoma in situ (CIS) of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on September 3, 2009 at 3:18 pm By:

eMPR MPR Medical Publisher

MPR News: Valstar available again for treatment of bladder cancer: Endo Pharmaceuticals has launched Va.. http://bit.ly/QfV2Z

3 years ago...

Induction BCG Sufficient for High-Risk NMIBC - Renal and Urology News

renalandurologynews.com — “Bacillus Calmette-Gu©rin (BCG) treatment without maintenance in patients with high-risk non-muscle-invasive bladder cancer (NMIBC) compares favorably with trials in which comparable patients received maintenance BCG.View full resource at renalandurologynews.com

  • View Related
  • Share

Most Recently Shared on May 5, 2011 at 6:01 pm By:

renalandurology Renal Urology News Urology, Medical Publisher, Health News, and Nephrology

Induction BCG Sufficient for High-Risk NMIBC: Bacillus Calmette-Guérin (BCG) treatment without maintenance in pa... http://bit.ly/lsTIZf

1 year ago...

Gemcitabine May Hold Promise for BCG Failures - Renal and Urology News

renalandurologynews.com — “Gemcitabine might be a second-line treatment option for patients with high-risk non-muscle-invasive bladder cancer (BC) who fail therapy with bacille Calmette-Gurin (BCG), according to Italian researchers.View full resource at renalandurologynews.com

  • View Related
  • Share

Most Recently Shared on March 30, 2010 at 5:14 pm By:

renalandurology Renal Urology News Urology, Medical Publisher, Health News, and Nephrology

Gemcitabine May Hold Promise for BCG Failures: Gemcitabine might be a second-line treatment option for patients wi... http://bit.ly/cOMQcN

2 years ago...

Drug May Be an Alternative to Cystectomy for BCG Failures - Renal and Urology News

renalandurologynews.com — “VIENNA--"Mycobacterial cell wall DNA complex (MCC) may provide an alternative to cystectomy for patients with non-muscle invasive bladder cancer refractory to bacillus Calmette-Gu©rin (BCG) treatment, according to preliminary study findings.View full resource at renalandurologynews.com

  • View Related
  • Share

Most Recently Shared on March 21, 2011 at 12:06 pm By:

renalandurology Renal Urology News Urology, Medical Publisher, Health News, and Nephrology

Drug May Be an Alternative to Cystectomy for BCG Failures: VIENNA—Mycobacterial cell wall DNA complex (MCC) may ... http://bit.ly/hfiFqe

1 year ago...

New investigational treatment for bladder cancer

physorg.com — “A team of researchers, led by Columbia University Medical Center faculty, has identified a new investigational therapy for the treatment of bladder cancer. The discovery was made using a new research model, using mice, which replicates many aspects of human bladder cancer. The model also enabled the ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on March 12, 2009 at 9:33 pm By:

FightCancer FightCancer Health News

New investigational treatment for bladder cancer http://tinyurl.com/b3cfmj

3 years ago...

Phase 3 study of Urocidin for the treatment of bladder cancer - MPR

empr.com — “Endo Pharmaceuticals and Bioniche Life Sciences announced enrollment of the first patient into their Phase 3 study of Urocidin in the intravesical treatment of patients with BCG (Bacillus Calmette-Gu©rin) recurrent or refractory non-muscle-invasive bladder cancer.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on February 17, 2011 at 8:52 pm By:

eMPR MPR Medical Publisher

MPR News: Phase 3 study of Urocidin for the treatment of bladder cancer: Endo Pharmaceuticals and Bioniche Life ... http://bit.ly/eiO0Wi

1 year ago...

TRPV2 Activation Induces Apoptotic Cell Death In Human T24 Bladder Cancer Cells: A Potential Therapeutic Target For Bladder Cancer

medicalnewstoday.com — “Bladder carcinoma is the second most common malignancy of the urinary tract and nearly 90% of all primary tumors of the bladder are urothelial carcinomas (UCs). Superficial UCs can be shaved offView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on August 11, 2010 at 10:41 am By:

Urology_Wisdom Urology & Nephrology OW Health

TRPV2 Activation Induces Apoptotic Cell Death In Human T24 Bladder Cancer Cells: A Potential Therapeutic Target Fo... http://mnt.to/f/3HcT

2 years ago...

Bladder cancer : The Lancet

thelancet.com — “Bladder cancer. By - Prof, Dr Donald S Kaufman MD, Prof William U Shipley MD, Adam S Feldman MDView full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on July 20, 2009 at 8:56 pm By:

NICE Unable To Recommend New Treatment For Bladder Cancer

medicalnewstoday.com — “In final draft guidance issued today, NICE has not been able to recommend vinflunine (Javlor, Pierre-Fabre) for the treatment of advanced or metastatic transitional cell carcinoma of the urotheliaView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 10, 2011 at 12:05 pm By:

mnt_urology MNT Urology Health News

NICE Unable To Recommend New Treatment For Bladder Cancer http://mnt.to/3S7y #urology

1 year ago...

Phase 3 study of Urocidin for bladder cancer - MPR

empr.com — “Bioniche Life Sciences announced that it has completed recruitment in its initial Phase 3 registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guerin (BCG).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on March 31, 2009 at 11:11 pm By:

eMPR MPR Medical Publisher

Phase 3 study of Urocidin for bladder cancer : Bioniche Life Sciences announced that it has completed recruitmen.. http://tinyurl.com/cfe9ln

3 years ago...

Radiation Therapy to Treat Bladder Cancer, Other Bladder Cancer Treatments - Bladder Cancer - Urology Channel

urologychannel.com — “Bladder cancer may be treated using radiation therapy, including external beam radiation and brachytherapy and other bladder cancer treatments.View full resource at urologychannel.com

  • View Related
  • Share

Most Recently Shared on September 27, 2010 at 2:55 pm By:

Oncology Article | Bladder cancer

mdlinx.com — “Vinflunine in the treatment of advanced bladder cancerView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on January 14, 2011 at 11:48 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Vinflunine in the treatment of advanced bladder cancer: Expert Review of Anticancer Therapy http://bit.ly/g2fuN2 #oncology

1 year ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

  • mnt_urology

    MNT Urology

    The latest urology/nephrology news published daily. Articles from research centers, universities and prestigious journals.

    View Profile

  • renalandurology

    Renal Urology News

    Renal and Urology News reports on clinical news for both nephrologists and urologists.

    View Profile

  • MedicalFeed

    MedicalFeed

    Medical news and updates about medical articles and discussion in Google knols and in many medical websites.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390